Why Might California’s 2023-2024 Education Budget Lack Billions in Funding?

Things are looking bleak for California’s 2023-2024 education budget and school year. As the state gears up for another legislative cycle and major funding decisions, the state’s nonpartisan Legislative Analyst Office is predicting a hole of $2.6 billion for schools and community colleges beginning in July 2023. Declining state revenues are keeping education funds tight, and persisting difficult economic conditions across the nation (though there are some signs of deflation), reinforce the possibility of an underfunded school year.

What are the specific mechanisms depressing California’s 2023-2024 education budget? And what are the possible consequences of this multibillion dollar deficit, especially on critical state programs? Curtis Culwell, Executive Director of the Texas School Alliance, gives his analysis on the situation and what he sees as the consequences of.

Curtis’ Thoughts on California’s 2023-2024 Education Budget

 

“As 2022 comes to a close, many states are wrapping up their budget process in anticipation of the legislative cycle that begins after the first of the year. Some of the early news out of California as they’re doing their budget analysis is the possible loss of billion dollars from education funding that is due like every other state becasue of some of the headwinds the economy has faced nationally as well as in the state. California’s three major revenue mechanisms are income tax, sales tax and corporate tax.

Like many states where the economy has slowed down then state revenues have possibly slowed down as well, and as you try to anticipate what ’23 and ’24 are going to be like, there is some concern and there is a growing conservative outlook about state expenditures.

 

In a state like California, I think almost 40% of their budget is K12 and community college funding. Those institutions are faced with significant headwinds as well in terms of the growing cost of goods and services. Some of the programs have been started to address learning lag because of the pandemic and many other educational initiatives that are needed for student performance to rebound.

 

So all those things that come together and present some significant challenges and we’ll all be watching what happens in California and other states with interest as they develop their budgets and how they grapple with some of these issues.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More